Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10862-10865

  Li, Hualin ^a   Rhee, Elizabeth G ^a   Masek Hammerman, Katherine ^b,d   Teigler, Jeffrey E ^a   Abbink, Peter ^a   Barouch, Dan H ^a,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD3 ANTIGEN; CD4 ANTIGEN; CD46 MONOCLONAL ANTIBODY 13 42; CELL PROTEIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR MONOCLONAL ANTIBODY RMCB; GAG NEF PROTEIN VACCINE; HLA DR ANTIGEN; KI 67 ANTIGEN; LAGERIN; MEMBRANE COFACTOR PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS RECEPTOR; VIRUS VACCINE;

ADENOVIRUS; ADENOVIRUS 35; ADENOVIRUS 5; ADENOVIRUS INFECTION; ADENOVIRUS SEROTYPE 26; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; COXSACKIE VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LYMPHOCYTE MIGRATION; MOUSE; MYELOID DENDRITIC CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRAL GENE DELIVERY SYSTEM; VIRUS IMMUNITY;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD46; COXSACKIE AND ADENOVIRUS RECEPTOR-LIKE MEMBRANE PROTEIN; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACACA MULATTA; T-LYMPHOCYTES; VACCINATION;

ADENOVIRIDAE; MACACA MULATTA;

EID: 84869022421     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00928-12     Document Type: Article

References (16)

1. Abbink P, et al. 2007. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from sub-groups B and D. J. Virol. 81:4654-4663.
2. Arnberg N. 2009. Adenovirus receptors: implications for tropism, treat-ment and targeting. Rev. Med. Virol. 19:165-178.
3. Barouch DH, et al. 2011. International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations. Vaccine 29:5203-5209.
4. Bergelson JM, et al. 1997. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275:1320-1323.
5. Buchbinder SP, et al. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893.
6. Chen H, et al. 2010. Adenovirus-based vaccines: comparison of vectors from three species of Adenoviridae. J. Virol. 84:10522-10532.
7. Ebbinghaus C, et al. 2001. Functional and selective targeting of adeno- virus to high-affinity Fcgamma receptor I-positive cells by using a bispe-cific hybrid adapter. J. Virol. 75:480-489.
8. Gaggar A, Shayakhmetov DM, Lieber A. 2003. CD46 is a cellular receptor for group B adenoviruses. Nat. Med. 9:1408-1412.
9. Hsu KH, Lonberg-Holm K, Alstein B, Crowell RL. 1988. A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J. Virol. 62:1647-1652.
10. Kolev MV, et al. 2010. Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration. Pharmacogenom-ics J. 10:12-19.
11. Liu J, et al. 2008. Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys. J. Virol. 82:4844-4852.
12. Masek-Hammerman K, et al. 2010. Mucosal trafficking of vector-specific CD4+ T lymphocytes following vaccination of rhesus monkeys with adenovirus serotype 5. J. Virol. 84:9810-9816.
13. Roelvink PW, et al. 1998. The coxsackievirus-adenovirus receptor pro- tein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 72:7909-7915.
14. Schneider-Schaulies J, Dunster LM, Schwartz-Albiez R, Krohne G, ter Meulen V. 1995. Physical association of moesin and CD46 as a receptor complex for measles virus. J. Virol. 69:2248-2256.
15. Seya T, Hara T, Matsumoto M, Akedo H. 1990. Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation. J. Immunol. 145:238-245.
16. Waddington SN, et al. 2008. Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132:397-409.